The Digest LabA daily digest of news releases

Health & Medical · Week of Nov 9, 2026

InMode, PAVmed report Q3 results: the week in health releases

PAVmed, Photocure, ComplexCare, CeraVe, Basata and others reported results, reimbursement updates, financing and campaigns; Medicare coverage was a recurring theme.

· The Digest Lab newsroom

Medicare reimbursement for molecular diagnostics ran through two of the week's releases. PAVmed says its subsidiary Lucid Diagnostics began receiving Medicare payments for the EsoGuard test in October after submitting claims to Novitas. Photocure says its AssureMDx bladder cancer test was left out of a Novitas Local Coverage Determination dated November 6, 2026, though it still expects coverage in 2028 and a CMS pricing decision before year-end.

On the financial side, InMode reported third-quarter GAAP revenues of $92.1 million and reaffirmed its 2026 outlook, and ComplexCare Solutions refinanced its senior secured credit facilities with Regions Bank and Pinnacle Bank. Other releases covered consumer and awareness campaigns from CeraVe and Breakthrough T1D, an AI scheduling deployment by Basata with Unio Health Partners, and the Global Wellness Institute's estimate that the wellness economy reached $7.5 trillion in 2025.

  1. InMode Ltd.

    InMode Reports Third Quarter 2026 Financial Results: Quarterly GAAP Revenues of $92.1 Million; Reaffirms Full-Year 2026 Financial Outlook

    InMode reported third-quarter 2026 GAAP revenues of $92.1 million, compared with $93.2 million a year earlier, and GAAP net income of $18.9 million, or $0.32 per diluted share, and reaffirmed 2026 revenue guidance of $365 million to $375 million. The company says GAAP operating margin fell to 19% from 22%, mainly due to a North American sales team restructuring, and that it will resume investor relations activities after its Special Committee completed its work.

  2. PAVmed Inc.

    PAVmed Provides Business Update and Reports Preliminary Third Quarter 2026 Financial Results

    PAVmed reported preliminary third-quarter results, including a non-GAAP adjusted net loss of approximately $1.2 million, and said Lucid Diagnostics began receiving Medicare payments for EsoGuard in October at the Clinical Laboratory Fee Schedule rate. Lucid performed 2,871 EsoGuard tests in 3Q26 with revenue of $1.2 million, and Veris Health started a 90-day GLP animal study ahead of a planned early 2027 FDA 510(k) submission.

  3. ComplexCare Solutions

    ComplexCare Solutions Closes Refinancing with Regions Bank and Pinnacle Bank, Lowering Cost of Capital and Enabling Long-term Growth

    ComplexCare Solutions, owned by Vesey Street Capital Partners, closed a refinancing with Regions Bank and Pinnacle Bank consisting of a revolving credit facility and a Term Loan A that repaid its existing term loan in full. The company says the deal lowers its interest rate and extends debt maturity to 2031 for the Nashville-based provider serving health plans in 43 states.

  4. CeraVe

    CeraVe Becomes "The Official Moisturizer of Arrakis" in First-Ever Film Partnership with DUNE: PART THREE

    CeraVe announced its first official film partnership, with Warner Bros. Pictures and Legendary Pictures' Dune: Part Three, branding itself "The Official Moisturizer of Arrakis" in a campaign centered on CeraVe Moisturizing Cream. The campaign launched globally on November 13, 2026 and runs through the film's release, which begins December 18, 2026 in North America.

  5. Photocure

    Photocure Provides Update on AssureMDx and Anticipated Medicare Coverage Timeline

    Photocure said AssureMDx was not included in the Novitas Local Coverage Determination dated November 6, 2026, which identifies additional clinical evidence needed for future reconsideration. The company says its Medicare coverage timeline remains aligned with its original 2028 assumption, with a CMS pricing determination expected before year-end 2026 and initial revenue still expected in 2027.

  6. Global Wellness Institute

    The Global Wellness Economy Hits New Record of $7.5 Trillion and Is Forecast to Reach $10.9 Trillion by 2030

    The Global Wellness Institute's Global Wellness Economy Monitor 2026 reports the wellness economy grew 8.9% to $7.5 trillion in 2025 and forecasts $10.9 trillion by 2030. GWI identifies wellness real estate and mental wellness as the fastest-growing sectors and says workplace wellness is the only stagnant sector, at 1.3% annual growth.

  7. Breakthrough T1D, Formerly JDRF

    Breakthrough T1D Honors World Diabetes Day with Expanded Global "See T1D" Campaign, Spotlighting Life with Type 1 Diabetes

    Breakthrough T1D expanded its "See T1D" awareness campaign to global channels for World Diabetes Day, including a Times Square digital billboard takeover. It also released "The State of T1D: The Burden Behind the Numbers," which says 39% of people with T1D experience diabetes distress and cites $16 billion in annual U.S. T1D-associated healthcare expenditures and lost income.

  8. Basata

    Basata and Unio Health Partners Partner to Accelerate Patient Access to Specialty Care

    Basata will deploy its AI orchestration platform for patient intake and scheduling across more than 60 Unio Specialty Care practice locations in California, handling referral documents, chart creation, insurance eligibility checks and AI voice agent outreach. The rollout will be phased with no full-deployment date given, and Basata says it does not make clinical decisions or train models on identifiable patient data.

This roundup is written with AI assistance from the press releases listed above, using only what they state. The releases are the companies' own announcements, not The Digest Lab reporting.